<?xml version="1.0" encoding="utf8"?>
 <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd"> <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Review Article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">IJGP</journal-id>
      <journal-title-group>
        <journal-title>International Journal of General Practice</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2692-5257</issn>
      <publisher>
        <publisher-name>Open Access Pub</publisher-name>
        <publisher-loc>United States</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.14302/issn.2692-5257.ijgp-22-4071</article-id>
      <article-id pub-id-type="publisher-id">IJGP-22-4071</article-id>
      <article-categories>
        <subj-group>
          <subject>Review Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Oral Ulceration </article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bronagh</surname>
            <given-names>McGuckin</given-names>
          </name>
          <xref ref-type="aff" rid="idm1840706532">1</xref>
          <xref ref-type="aff" rid="idm1840706316">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brian</surname>
            <given-names>Swinson</given-names>
          </name>
          <xref ref-type="aff" rid="idm1840706532">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1840706532">
        <label>1</label>
        <addr-line>Department of Oral and Maxillofacial Surgery, Altnagelvin Area Hospital, Western Health and Social Care Trust, Northern Ireland, UK. </addr-line>
      </aff>
      <aff id="idm1840706316">
        <label>*</label>
        <addr-line>corresponding author</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Yang</surname>
            <given-names>Song</given-names>
          </name>
          <xref ref-type="aff" rid="idm1840848036">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1840848036">
        <label>1</label>
        <addr-line>Department of Pharmacy Services, CHI Franciscan Health, St. Joseph Medical Center, Tacoma, WA 98405, USA.</addr-line>
      </aff>
      <author-notes>
        <corresp>Bronagh McGuckin, Health Center Santa Maria de, Benquerencia, Toledo, Spain <email>bronagh.mcguckin@gmail.com</email></corresp>
        <fn fn-type="conflict" id="idm1842002812">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub" iso-8601-date="2023-03-25">
        <day>25</day>
        <month>03</month>
        <year>2023</year>
      </pub-date>
      <volume>1</volume>
      <issue>3</issue>
      <fpage>1</fpage>
      <lpage>8</lpage>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>01</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>01</month>
          <year>2022</year>
        </date>
        <date date-type="online">
          <day>25</day>
          <month>03</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© </copyright-statement>
        <copyright-year>2023</copyright-year>
        <copyright-holder>Bronagh McGuckin, et al.</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://openaccesspub.org//ijgp/article/1922">This article is available from http://openaccesspub.org//ijgp/article/1922</self-uri>
      <abstract>
        <p>Oral ulceration is a common disorder of the oral mucosa with individuals regularly                  presenting to primary care practitioners seeking advice and treatment. Diagnosis of oral ulceration remains a challenge for clinicians due to the               overlap in clinical presentations and the diverse aetiological processes that can be involved in their development. A recent study evaluating general medical practitioners’ attitudes towards oral             examination identified problems in clinicians’                     confidence in differentiating between benign and             malignant ulcers, with a lack of knowledge and                     training being cited as contributing factors. This                 article aims to provide an overview of the diagnosis and management of oral ulceration, providing a framework to guide clinical decision-making in a              primary care setting. </p>
      </abstract>
      <kwd-group>
        <kwd>Ulcer</kwd>
        <kwd>oral medicine</kwd>
        <kwd>oral cancer</kwd>
      </kwd-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="4"/>
        <page-count count="5"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="idm1840576340" sec-type="intro">
      <title>Introduction</title>
      <p>An ulcer is defined as a “break in the skin or mucous membrane which fails to heal leading to a loss of surface tissue, disintegration and epithelial necrosis” <xref ref-type="bibr" rid="ridm1849662516">3</xref>. Oral ulcers are common, with individuals presenting to primary care                  practitioners complaining of pain, discomfort and functional compromise. Due to the variety of                     presenting clinical features and causative factors, diagnosis of oral ulcerative lesions may be relatively challenging. Fortunately, the majority of oral ulcers are benign and can be managed using a variety of medications. </p>
      <p> A small proportion of ulcers are malignant, with 6,500 cases of oral cancers diagnosed in the UK every year <xref ref-type="bibr" rid="ridm1849498020">8</xref>. Over 95% of oral cancers are oral squamous cell carcinomas (SCC) and the major risk factors for these are smoking and alcohol consumption <xref ref-type="bibr" rid="ridm1849653868">2</xref>. The main treatment for oral cavity SCC is surgery with              complementary radiotherapy, chemotherapy or both to reduce the possibility of recurrence. The National Institute for Health and Care Excellence (NICE) has developed                national referral guidelines to accelerate the process from initial referral by a generalist to be seen by a specialist within two weeks of referral <xref ref-type="bibr" rid="ridm1849505308">7</xref>. It has been shown that timely diagnosis of oral SCC reduces mortality. A survey recently showed that 66-69% of patients with an oral               ulcer would first approach their general medical                     practitioner (GMP) for advice, therefore it is imperative that GMPs are confident in the diagnosis and management of such ulcers <xref ref-type="bibr" rid="ridm1849509844">5</xref>.</p>
      <sec id="idm1840576772">
        <title>Aetiology</title>
        <p>Causes of oral ulceration can range from localised trauma to oral cancer or a manifestation of systemic               disease. A surgical sieve approach to differential diagnosis, shown in <xref ref-type="table" rid="idm1841912316">Table 1</xref>, provides a useful framework to consider various types of pathologies systematically <xref ref-type="bibr" rid="ridm1849724284">4</xref>.</p>
        <table-wrap id="idm1841912316">
          <label>Table 1.</label>
          <caption>
            <title> Surgical sieve approach to oral ulceration (Ferneini and Goupil, 2019)</title>
          </caption>
          <table rules="all" frame="box">
            <tbody>
              <tr>
                <td>Reactive</td>
                <td>
                  <bold>Traumatic ulcers</bold>
                </td>
              </tr>
              <tr>
                <td>Local factors: restorations, margins, sharp teeth, irritant</td>
                <td>Chemical burns (e.g. aspirin burn)</td>
              </tr>
              <tr>
                <td>Generally acute/patient recalls specific cause</td>
                <td> </td>
              </tr>
              <tr>
                <td>Heal within 10–14 days</td>
                <td> </td>
              </tr>
              <tr>
                <td>Can be chronic if irritant/agent persists</td>
                <td> </td>
              </tr>
              <tr>
                <td>Generally painful</td>
                <td> </td>
              </tr>
              <tr>
                <td>Heal if irritant is removed/scarring with chronic ulcers</td>
                <td> </td>
              </tr>
              <tr>
                <td>Predisposing factors: oral dryness</td>
                <td> </td>
              </tr>
              <tr>
                <td>Infectious diseases<italic> </italic></td>
                <td> </td>
              </tr>
              <tr>
                <td>Children</td>
                <td>Herpetic infection (primary or secondary)</td>
              </tr>
              <tr>
                <td>Primary and recurrent episodes</td>
                <td>Coxsackie virus infection</td>
              </tr>
              <tr>
                <td>Acute onset: lasts 10–14 days</td>
                <td> </td>
              </tr>
              <tr>
                <td>Multiple ulcers; distribution depends on type of infection</td>
                <td> </td>
              </tr>
              <tr>
                <td>Pain</td>
                <td> </td>
              </tr>
              <tr>
                <td>Signs/symptoms: fever, malaise, lymphadenopathy</td>
                <td> </td>
              </tr>
              <tr>
                <td>Recurrences</td>
                <td> </td>
              </tr>
              <tr>
                <td>Local immune-dysregulation</td>
                <td> </td>
              </tr>
              <tr>
                <td>Acute onset</td>
                <td>Recurrent aphthous stomatitis</td>
              </tr>
              <tr>
                <td>Duration: 10–14 days</td>
                <td>Erythema multiforme (E.M.)</td>
              </tr>
              <tr>
                <td>Pain</td>
                <td> </td>
              </tr>
              <tr>
                <td>Multiple ulcers</td>
                <td> </td>
              </tr>
              <tr>
                <td>Distribution: oral mucosal (aphthous); oral + extraoral (E.M.)</td>
                <td> </td>
              </tr>
              <tr>
                <td>Recurrent episodes (aphthous; E.M. if trigger persists)</td>
                <td> </td>
              </tr>
              <tr>
                <td> Immune-mediated conditions</td>
                <td> </td>
              </tr>
              <tr>
                <td>Adults</td>
                <td>Lichen planus</td>
              </tr>
              <tr>
                <td>Chronic and progressive</td>
                <td>Mucous membrane pemphigoid</td>
              </tr>
              <tr>
                <td>Multiple ulcers: unrelated to local physical factors</td>
                <td>Pemphigus vulgaris</td>
              </tr>
              <tr>
                <td>Distribution: oral + extraoral (skin, conjunctiva, genital etc.)</td>
                <td> </td>
              </tr>
              <tr>
                <td>Persistent ulcers; recurring and overlapping episodes</td>
                <td> </td>
              </tr>
              <tr>
                <td>Hx of underlying systemic condition</td>
                <td> </td>
              </tr>
              <tr>
                <td>Neoplastic</td>
                <td> </td>
              </tr>
              <tr>
                <td>Clinically obvious mass/tumour</td>
                <td>Squamous cell carcinoma</td>
              </tr>
              <tr>
                <td>Solitary ulceration; persistent; chronic ulceration (3–4 weeks)</td>
                <td>Malignant salivary gland neoplasms</td>
              </tr>
              <tr>
                <td>Unrelated to local physical factors</td>
                <td> </td>
              </tr>
              <tr>
                <td>
                  <italic>Cancer prone oral locations: ventral/lateral tongue, floor of</italic>
                  <italic> mouth, retromolar pad</italic>
                </td>
                <td> </td>
              </tr>
              <tr>
                <td>Pain, paraesthesia</td>
                <td> </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="idm1840511796">
              <label/>
              <p>Permission required. </p>
            </fn>
            <fn id="idm1840512516">
              <label/>
              <p>Publisher: Springer
Book title: Evidence-based oral surgery: a clinical guide for the general dental practitioner.
Authors' names: EM Ferneini, MT Goupil
Volume number, issue date, page numbers: 1<sup>st</sup> Edition (2019), Chapter 17, page 353
Specific figure numbers or portion of text: Table 17.3</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="idm1840513524">
        <title>Traumatic Ulcers </title>
        <p>Traumatic ulcers are the most common oral ulcer and usually present as single, painful, irregular ulcer.                 Classically, patients recall an incident that preceded the development of the ulcer such as cheek/tongue bite or may be aware of a sharp tooth or restoration. Clinically, they present as a single shallow yellow-white ulcer with irregular, erythematous borders which heal within three weeks of the initial injury. Traumatic ulcers will persist or recur if the stimulus is not resolved.  </p>
      </sec>
      <sec id="idm1840512732">
        <title>Recurrent Aphthous Stomatitis (RAS)</title>
        <p>Recurrent aphthous stomatitis (RAS) is an acute ulcerative disease of local immune dysregulation and is the second most common oral ulcerative condition with a global prevalence of 25% <xref ref-type="bibr" rid="ridm1849653220">1</xref>.  RAS frequently commences in young adulthood and predisposing factors that have been identified include: genetic factors, local factors such as trauma or exposure to particular foods, haematinic       deficiency, and systemic conditions such as Crohn’s              disease. </p>
        <p>Clinically, patients with RAS present with painful ulcers affecting the non-keratinised mucosal surfaces (e.g. buccal mucosa, floor of the mouth, ventral tongue and soft palate), which are round-to-ovoid with a yellow-white fibrinonecrotic centre and erythematous borders. Given the acute nature of RAS, ulcers can present suddenly and typically last for 7-10 days, with some patients reporting specific inciting triggers. RAS is classified depending on the size of ulcers: minor (less than 1cm diameter) which usually heals spontaneously within two weeks, major (more than 1cm diameter) which may take longer than three weeks to resolve and herpetiform (1-2mm                  diameter) which present as a cluster of ulcers. RAS is self-limiting, but in severe cases topical or systemic                     corticosteroids are recommended. Specialist referral for further investigation is indicated when episodes of lesions become more severe, late-onset RAS, or when lesions are accompanied by systemic symptoms.</p>
      </sec>
      <sec id="idm1840510068">
        <title>Drugs </title>
        <p>Oral ulceration can be the result of the use of drugs themselves. Oral mucosal burns are seen when drugs are inappropriately applied topically to the gingivae e.g. aspirin near a toothache or use of illicit drugs such as cocaine. Lichenoid reaction, similar in appearance to                     lichen planus, is associated with a number of drugs such as ACE inhibitors and NSAID. Some drugs may cause oral ulceration directly e.g. nicorandil, which will persist until the drug reduced or withdrawn. Anti-resorptive drugs such as bisphosphonates and denosumab have been linked to medication-related osteonecrosis of the jaws, often presenting as a non-healing ulceration of the                  overlying oral mucosa with exposed necrotic bone which is very challenging to manage and requires specialist               referral. </p>
      </sec>
      <sec id="idm1840511004">
        <title>Squamous Cell Carcinoma</title>
        <p>Squamous cell carcinoma (SCC) represents about 95% of all oral malignancies and accounts for 1-2% of all cancers worldwide. Approximately 80% of patients are aged 40+ years and it is twice as common in men than women, with tobacco smoking and alcohol as risk                    factors <xref ref-type="bibr" rid="ridm1849653868">2</xref>. Clinical presentation can range from a red, white or red-white patches to an ulcerative lesion.                  Commonly, they present as asymptomatic, slow-growing, non-healing ulcers with raised rolled borders and high risk sites include the ventral or lateral surface of the tongue, the floor of mouth or the soft palate. On                     presentation, 30% of patients will have involvement of the submandibular and cervical lymph nodes <xref ref-type="bibr" rid="ridm1849653868">2</xref>. Given the destructive nature of SCCs, a timely and accurate diagnosis is key to improving the patients’ prognosis. Management usually involves a combination of therapeutic modalities including surgery, radiotherapy and occasionally                   chemotherapy. </p>
      </sec>
      <sec id="idm1840509636">
        <title>Lichen Planus</title>
        <p>Lichen planus is a chronic T-lymphocyte mediated inflammatory disease of skin and mucous membranes with characteristic oral lesions. It generally affects females more than males and middle-aged patients. There are     various clinical presentations including erosive/ulcerative, reticular, bullous and papular lesions with the frequently affected sites being the buccal mucosa, palate, gingivae and tongue. It is considered a pre-malignant               lesion therefore correct diagnosis and long-term follow-up with a specialist is important. The mainstay of treatment remains topical and systemic corticosteroids. </p>
      </sec>
      <sec id="idm1840510716">
        <title>Mucous Membrane Pemphigoid</title>
        <p>Mucous membrane pemphigoid (MMP) is a          chronic, immunobullous condition mainly affecting the oral mucosa.It is predominantly a disease of the older population and is twice as common in women than men. The most commonly affected site in the oral cavity is the gingivae, with a characteristic desquamative gingivitis presentation, followed by the buccal mucosa and palate. Lesions may also affect the eyes, skin, nose and genitalia. Patients suspected of having MMP should be referred for specialist care and symptoms can be managed with topical or systematic corticosteroids. </p>
      </sec>
      <sec id="idm1840510572">
        <title>Pemphigus Vulgaris</title>
        <p>Pemphigus vulgaris is a rare, potentially                         life-threatening chronic autoimmune condition which is characterised by epithelial blistering of mucocutaneous surfaces. Oral lesions begin as fragile bullae which                  rupture, resulting in large, irregular, painful ulcers/erosions. The lesions are most frequently observed in the buccal mucosa, palate and gingivae. Skin lesions may                                             appear several months later. Timely specialist referral is key to promote healing of lesions, prevent infection,                decrease frequency of new lesions and control                       symptoms.  High dose systemic corticosteroids such as prednisolone combined with an adjuvant                                     immunosuppressant such as azathioprine remain the gold standard treatment. </p>
      </sec>
      <sec id="idm1840510284">
        <title>Infection</title>
        <p>Primary herpetic gingivostomatitis is the most common manifestation of<italic> the primary herpes simplex virus</italic> and is typically seen in children and young adults. Oral features consist of  multiple vesicles affecting the oral                    mucosa which rupture forming painful ulcers with a red, elevated halo-margin and a depressed yellow-white                   pseudomembrane. The ulcers usually heal spontaneously within one week however may persist in more severe       cases. </p>
        <p>Herpes zoster infection due to reactivation of<italic> varicella-zoster virus</italic> can also result in oral ulceration. Clinically, clustered ulcers (less than 5mm in diameter) appear on the buccal gingivae or hard palate in a                   characteristic unilateral pattern, and tend to heal within two weeks. Management for viral infections is directed toward pain control and hydration, with the use of                     antivirals only effective when started within 72 hours of disease onset. </p>
      </sec>
      <sec id="idm1840523748">
        <title>Erythema Multiforme</title>
        <p>Erythema multiforme is an uncommon                       mucocutaneous hypersensitivity reaction triggered by a range of exogenous factors e.g. medications, infections such as herpes simplex virus and mycoplasma infection, and food additives or chemicals. It typically affects young males and is characterised by ‘target lesions’ on the skin and macules on the lips and buccal mucosa which evolve to bullae and ulcers with irregular borders with an                  inflammatory halo. Prodromal signs such as fever,                      lymphadenopathy, and malaise may be noticed prior to onset of mucocutaneous erythema or blisters. In the mild forms, healing takes place within three weeks; therefore, patients only need local wound care, liquid diet, and to                   pical analgesics for pain control, however, in more severe cases, patients should be referred for treatment with                   systemic corticosteroids or other immunomodulatory drugs. <xref ref-type="fig" rid="idm1841789660">Figure 1</xref>, <xref ref-type="fig" rid="idm1841788364">Figure 2</xref></p>
        <fig id="idm1841789660">
          <label>Figure 1.</label>
          <caption>
            <title> Clinical presentations of oral ulceration</title>
          </caption>
          <graphic xlink:href="images/image1.jpg" mime-subtype="jpg"/>
        </fig>
        <fig id="idm1841788364">
          <label>Figure 2.</label>
          <caption>
            <title> Clinical presentations of oral ulceration</title>
          </caption>
          <graphic xlink:href="images/image2.jpg" mime-subtype="jpg"/>
        </fig>
      </sec>
      <sec id="idm1840480836">
        <title>Diagnosis</title>
        <sec id="idm1840481412">
          <title>History </title>
          <p>A structured approach to history-taking is vital to establish the pattern and frequency of ulceration, which in turn, allows a differential and ultimately a definitive                   diagnosis to be determined. A useful mnemonic to guide history-taking is the SOCRATES approach, outlined in                 <xref ref-type="table" rid="idm1841912316">Table 1</xref>. This should be followed by a systematic medical history, noting any dermatological, ophthalmological,                  haematological, gastrointestinal, and rheumatological manifestations. Common drugs which have been                                             associated with oral ulceration include NSAIDs, nicorandil and anti-hypertensives. Drug-related ulceration will                                   resolve with either dose reduction or complete cessation of the medication. Risk factors for oral cancer should be identified and evaluated such as alcohol consumption and tobacco use. Additionally, a brief dental history can                   ascertain if any recent treatment has been carried out or any appliance is being worn and causing irritation. <xref ref-type="table" rid="idm1841787068">Table 2</xref></p>
          <table-wrap id="idm1841787068">
            <label>Table 2.</label>
            <caption>
              <title> Ulceration history</title>
            </caption>
            <table rules="all" frame="box">
              <tbody>
                <tr>
                  <td>Site</td>
                  <td>Location of ulcer(s)</td>
                </tr>
                <tr>
                  <td><bold>O</bold>nset</td>
                  <td>Duration of current episode, Date of first episode</td>
                </tr>
                <tr>
                  <td><bold>C</bold>haracteristics</td>
                  <td>Pain, Painless</td>
                </tr>
                <tr>
                  <td><bold>R</bold>adiation</td>
                  <td>Lesions or ulcers elsewhere in the body</td>
                </tr>
                <tr>
                  <td><bold>A</bold>ssociated symptoms</td>
                  <td>Systemic upset at time of ulceration</td>
                </tr>
                <tr>
                  <td><bold>T</bold>iming</td>
                  <td>Period of time between episodes</td>
                </tr>
                <tr>
                  <td><bold>E</bold>xacerbating and relieving factors</td>
                  <td>Particular foods e.g. spicy foods, Analgesics required</td>
                </tr>
                <tr>
                  <td>Severity</td>
                  <td>Able to eat/drink, Night-waking</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec id="idm1840470900">
          <title>Examination </title>
          <p>The examination should begin with an extra-oral examination, visually inspecting and palpating the head and neck region to detect any swelling or                                      lymphadenopathy. This should be followed by an                     intra-oral examination, which requires an adequate light source and ideally a dental mirror or tongue depressor to allow full inspection of the oral mucosa. A systematic                      approach to this examination, beginning with the lips,                   followed by the cheek mucosa, floor of mouth, tongue, teeth and gums and palate, will avoid a lesion being missed. The ulcer(s) should be inspected with respect to: site, size, shape, margin, base and consistency. The                                                                                                                                                                                                                                                                                           presence of any prosthesis, sharp teeth or dental                       restoration, in relation to an ulcer should be recorded. Clinical features of an ulcer which should raise suspicion are outlined in <xref ref-type="table" rid="idm1841759604">Box 1</xref>.</p>
          <table-wrap id="idm1841759604">
            <label>Box 1.</label>
            <caption>
              <title> Clinical features of malignant oral ulcer</title>
            </caption>
            <table rules="all" frame="box">
              <tbody>
                <tr>
                  <td>Single ulcer</td>
                </tr>
                <tr>
                  <td>Painless</td>
                </tr>
                <tr>
                  <td>Present for more than 3 weeks</td>
                </tr>
                <tr>
                  <td>Granular floor</td>
                </tr>
                <tr>
                  <td>Rolled thickened edge</td>
                </tr>
                <tr>
                  <td>Lack of inflammation surrounding ulcer</td>
                </tr>
                <tr>
                  <td>Sites including floor of mouth, lateral and ventral surfaces of tongue, soft palate</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
      </sec>
      <sec id="idm1840467012">
        <title>Management</title>
        <sec id="idm1840466508">
          <title>Symptomatic Relief </title>
          <p>Due to the often painful nature of ulceration,             patients may require symptomatic relief prior to the                establishment of a definitive diagnosis. A variety of                                                                                                                                                                                                                                                                                         pharmacological modalities can be utilised, these include: warm saline mouth rinses, topical analgesic and                         anti-inflammatories (e.g. benzydamine hydrochloride), antimicrobial agents (e.g. chlorhexidine gluconate),                         physical barrier applications (e.g. carmellose gelatine), topical anaesthetics (e.g. lidocaine hydrochloride),                       systemic analgesics and topical and systemic                         corticosteroids (e.g. betamethasone, prednisolone).                       Examples of topical preparations are shown in <xref ref-type="table" rid="idm1841751540">Box 2</xref><xref ref-type="bibr" rid="ridm1849506100">6</xref>. </p>
          <table-wrap id="idm1841751540">
            <label>Box 2.</label>
            <caption>
              <title> Topical preparations</title>
            </caption>
            <table rules="all" frame="box">
              <tbody>
                <tr>
                  <td>
                    <bold>Topical </bold>
                    <bold>anaesthetic</bold>
                  </td>
                </tr>
                <tr>
                  <td>Lidocaine hydrochloride 5% ointment or 10% spray apply as required, rub sparingly and gently on affected areas.</td>
                </tr>
                <tr>
                  <th>
                    <bold>Topical analgesics/anti-inflammatory agent</bold>
                  </th>
                </tr>
                <tr>
                  <td>Benzydamine hydrochloride 0.15% mouthwash or oromucosal spray, rinse 15ml or spray 4-8 times every 1.5-3 hours as required. </td>
                </tr>
                <tr>
                  <th>
                    <bold>Topical antimicrobial agents</bold>
                  </th>
                </tr>
                <tr>
                  <td>Chlorhexidine gluconate 0.2% mouthwash or spray, rinse 10ml four times daily or apply up to 12 sprays twice daily to ulcer surface. </td>
                </tr>
                <tr>
                  <th>
                    <bold>Topical corticosteroids</bold>
                  </th>
                </tr>
                <tr>
                  <td>Betamethasone 500 micrograms soluble tablets, dissolved in 20ml water and rinsed around the mouth, not to be swallowed, up to four times daily.</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec id="idm1840451652">
          <title>Special Investigations </title>
          <p>Haematological investigations are useful and can exclude any underlying causes of ulceration such as iron, vitamin B12 or folic acid deficiency or deficiencies? If cancer is suspected, a tissue biopsy must be performed by an Oral Medicine/Maxillofacial specialist. </p>
        </sec>
      </sec>
      <sec id="idm1840448196">
        <title>Referral </title>
        <p>When there is a high suspicion that an ulcer is of traumatic origin due to a dental prostheses or restoration, the patient should be advised to contact their general    dental practitioner. </p>
        <p>If an ulcer persists for more than three weeks, in the absence of obvious traumatic aetiology, a red flag               referral should be made to the local Oral Medicine or               Maxillofacial Surgery Department. Additionally, recurrent ulceration, or ulcers with a systemic background or                 requiring further investigations may also benefits from specialist referral. </p>
      </sec>
      <sec id="idm1840448556">
        <title>Key Points </title>
        <p>Oral ulceration is common and mostly benign </p>
        <p>A detailed history and thorough examination will aid diagnosis and management</p>
        <p>Suspicious oral lesions can present in a wide variety of forms and patients with an ulcer persisting for more than three weeks should be referred urgently to an Oral Medicine or Maxillofacial specialist</p>
        <p>Alcohol and tobacco smoking are key risk factors for the development of oral cancer</p>
        <p> Referral to secondary care for specialist opinion is appropriate in cases where the potent topical           corticosteroids and systemic therapy is likely to be required</p>
        <p> Clinical photographs (taken with patient consent)   attached to the referral will benefit accepting clinicians </p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>Clinical photographs all original with consent for                          publication and are copyright of Belfast Health and Social Care Trust. </p>
    </ack>
    <ref-list>
      <ref id="ridm1849653220">
        <label>1.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Barrons</surname>
            <given-names>R W</given-names>
          </name>
          <article-title>Treatment strategies for recurrent oral aphthous ulcers</article-title>
          <date>
            <year>2001</year>
          </date>
          <source>Am J</source>
          <volume>58</volume>
          <issue>1</issue>
          <fpage>41</fpage>
          <lpage>50</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849653868">
        <label>2.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Cancer</surname>
            <given-names>Research UK</given-names>
          </name>
          <article-title>Mouth and oropharyngeal cancer 2018. Available at: https://www.cancerresearchuk.org/about-cancer/mouth-cancer(accessed 10</article-title>
          <date>
            <year>2018</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1849662516">
        <label>3.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Edsberg</surname>
            <given-names>L E</given-names>
          </name>
          <name>
            <surname>Black</surname>
            <given-names>J M</given-names>
          </name>
          <name>
            <surname>Goldberg</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Revised National Pressure Ulcer Advisory Panel Pressure Injury Staging System: Revised Pressure Injury Staging System</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Wound Ostomy</source>
          <volume>43</volume>
          <issue>6</issue>
          <fpage>585</fpage>
          <lpage>597</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849724284">
        <label>4.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Ferneini</surname>
            <given-names>E M</given-names>
          </name>
          <name>
            <surname>Goupil</surname>
            <given-names>M T</given-names>
          </name>
          <article-title>(2019)Evidence-based oral surgery: a clinical guide for the general dental practitioner</article-title>
          <publisher-name>Springer</publisher-name>
          <publisher-loc>Switzerland:</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1849509844">
        <label>5.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Gill</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Scully</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Mouth ulcers: a study of where members of the general public might seek advice</article-title>
          <date>
            <year>2007</year>
          </date>
          <source>Br Dent J</source>
          <volume>202</volume>
          <fpage>16</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849506100">
        <label>6.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <article-title>British national formulary 81. London: BMJ Publishing and the Royal Pharmaceutical Society</article-title>
          <date>
            <year>2021</year>
          </date>
          <institution>Joint Formulary Committee</institution>
        </mixed-citation>
      </ref>
      <ref id="ridm1849505308">
        <label>7.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Excellence</surname>
            <given-names>Care</given-names>
          </name>
          <article-title>Suspected cancer: recognition and referral. Suspected cancer: recognition and referral</article-title>
          <date>
            <year>2015</year>
          </date>
          <institution>National Institute of Health</institution>
        </mixed-citation>
      </ref>
      <ref id="ridm1849498020">
        <label>8.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Excellence</surname>
            <given-names>Care</given-names>
          </name>
          <article-title>Head and neck cancers – recognition and referral. The NICE Clinical Knowledge Summaries (CKS) site is only available to users in the UK, Crown Dependencies and British Overseas Territories</article-title>
          <date>
            <year>2020</year>
          </date>
          <institution>National Institute of Health</institution>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
